MV4 Mewah Intl
- 0.265
- -0.005-1.85%
Mewah Intl News
Individual Investors Own 24% of Mewah International Inc. (SGX:MV4) Shares but Private Companies Control 55% of the Company
Meihua International Medical Technology Co., Ltd. announces 2023 financial results
Yangzhou, April 24, 2024/PRNewswire/ -- Meihua International Medical Technology Co., Ltd. (“MHUA” or the “Company”) (NASDAQ: MHUA), a reputable manufacturer and supplier of Class I, II, and Class III disposable medical devices with operating subsidiaries in China, today announced financial results for the full year ended December 31, 2023. All amounts below are in US dollars. Financial highlights for the full year of 2023: Revenue remained stable and fell slightly by 6% to $97.1 million in 2023, compared to $103.3 million in 2022
Mewah International (SGX:MV4) Shareholders Will Want The ROCE Trajectory To Continue
With EPS Growth And More, Mewah International (SGX:MV4) Makes An Interesting Case
Changes in US stocks | Meihua International rose more than 8% in the pre-market and is about to launch the Speed Fox platform
GLONGHUI, November 20 | Meihua International (MHUA.US) rose 8.21% to $2.11 in the premarket. According to the news, the company is about to launch an innovative AI intelligent warehouse management and medical device logistics platform Speed Fox. The platform was developed by MHUA in collaboration with an outstanding team from a well-known higher education institution in China. MHUA believes that Speed Fox represents the company's strategic initiative aimed at broadening its business and revolutionizing the field of medical device logistics.
Meihua International Healthcare is about to launch the Speed Fox platform
(Pharma News, November 20, 2023) Meihua International Medical Technology Co., Ltd. (MHUA) announced that it will soon launch an innovative AI intelligent warehouse management and medical device logistics platform, Speed Fox. The platform was developed by MHUA in collaboration with an outstanding team from a well-known higher education institution in China. MHUA believes that Speed Fox represents the company's strategic initiative aimed at broadening its business and revolutionizing the field of medical device logistics. Under the banner of innovation, MHUA launched the Speed Fox program earlier this year, taking full advantage of the cutting-edge power of ChatGPT tools
Meihua International Healthcare Releases Advanced Warehouse Management and Medical Device Logistics Platform Speed Fox
Yangzhou, November 17, 2023/PRNewswire/ -- Meihua International Medical Technology Co., Ltd. (“MHUA” or “Company”) (NASDAQ: MHUA), a reputable manufacturer and supplier of Class 1, 2, and 3 disposable medical devices with operating subsidiaries in China, announced today that it will soon launch an innovative AI intelligent warehouse management and medical device logistics platform, Speed Fox. The platform was developed by an outstanding team of MHUA and a well-known higher education institution in China (hereinafter referred to as the “institution”). MHUA believes SPE
Mewah International (SGX:MV4) Shareholders Have Endured a 14% Loss From Investing in the Stock a Year Ago
Meihua International Medical Co., Ltd. established a subsidiary focusing on introducing internationally patented pharmaceuticals and medical device technology in Lecheng Pioneer Zone, Hainan
Yangzhou, October 31, 2023 /PRNewswire/ -- Meihua International Medical Technology Co., Ltd. (“Meihua” or “Company”) (NASDAQ: MHUA), a reputable manufacturer and supplier of first-class, second-class, and third-class disposable medical devices with operating subsidiaries in China, announced today the establishment of a holding subsidiary in Hainan Ruiying Technology Co., Ltd. (“Ruiying Technology”) in Boao Lecheng Pioneer Zone, Qionghai City, Hainan Province (“Ruiying Technology”). The newly established Ruiying Technology Plan leverages the policy advantages of the Lecheng Pioneer Zone to focus on introducing the Chinese market
Meihua International Medical Technology Co., Ltd. starts construction of a high-end comprehensive medical industrial park in Lecheng, Hainan
(Pharmaceutical News, October 27, 2023) Meihua International Medical Technology Co., Ltd. announced that construction of land surrounding the Lecheng International Medical Pilot Zone in Qionghai, Hainan, which was previously purchased, has officially started. The project anticipates the construction of a high-end comprehensive medical industrial park. The company completed the final payment for the land in Lecheng, Hainan in the first half of this year, and officially obtained the right to use the land for 50 years with a total area of 47,971 square meters. The newly built comprehensive medical industrial park will mainly focus on R&D, production, and testing of surgical robots. The company's surgical robotics technology will be developed and produced in collaboration with an Israeli company
Mewah International Inc.'s (SGX:MV4) Largest Shareholders Are Private Companies With 55% Ownership, Individual Investors Own 24%
Why We Like The Returns At Mewah International (SGX:MV4)
Here's Why We Think Mewah International (SGX:MV4) Is Well Worth Watching
Mewah International Unit Secures $120 Million Loan Facilities
Mewah International (SGX:MV4) said its subsidiary, PT Agro Murni, has secured term loan and working capital banking facilities worth $120 million from Bank Negara Indonesia (Persero) (IDX:BBNI). The S
Mewah International Books Lower Profit, Revenue in H1
Mewah International's (SGX:MV4) profit attributable to equity holders dropped 28.4% to $10.2 million, or $0.0068 per share, in the first half, from $14.2 million, or $0.0095 per share, a year ago. Rev
Mewah International's (SGX:MV4) Investors Will Be Pleased With Their Notable 60% Return Over the Last Three Years
Have Mewah International Insiders Been Selling Stock? \
Some Mewah International Inc. (SGX:MV4) shareholders may be a little concerned to see that insider Seng Cheo recently sold a substantial S$8.3m worth of stock at a price of S$0.42 per share. That's
Mewah International Inc.'s (SGX:MV4) Top Owners Are Private Companies With 55% Stake, While 23% Is Held by Individual Investors
Meihua International Medical's subsidiary will bring 12 new products to the 87th China International Medical Equipment Fair
Yangzhou, China, May 15, 2023 /PRNewswire/ -- Meihua International Medical Technology Co., Ltd. (“MHUA” or the “Company”) (NASDAQ: MHUA), a reputable Class I, Class II and Class III disposable medical device manufacturer and supplier with operating subsidiaries in China, announced today that its wholly-owned subsidiary Jiangsu Huadong Medical Devices Co., Ltd. (“Jiangsu Huadong”) will be invited to participate in China's largest and most prestigious medical industry exhibition for the 12th time in a row -- the 87th China International Medical Equipment Fair (”) CMEF”). The exhibition will be held on 20
Investors Shouldn't Overlook Mewah International's (SGX:MV4) Impressive Returns On Capital
Analysis
Price Target
No Data
